#

SM-ICG Hemodynamic Monitors

Clinical Benefits

NON-INVASIVE

• Fewer constraints: 

Complete safety for the patient
        No risk of infection or injury
Saves time for patient care

• More flexibility: 

Extensive applications (measurements at rest and during exercise)
Snapshots or continuous monitoring
Can be used routinely by nurses and/or technicians

RELIABLE
  • Unmatched reproducibility and sensitivity
  • Good agreement with reference methods at rest (incl. severely ill patients) and during exercise
  • Proven clinical value even in difficult patients and challenging measurement conditions
  • High quality standards: 
         Excellence in manufacturing and customer service
         ISO 9001/13485 standards
         Market approvals in the USA (FDA), Europe, Japan, among other.
EASY TO USE
  • User friendly, MS-Windows™ based software: 
         Works in every application
         Detailed printed report and data export to text and MS-Excel™ files
  • Easy to handle hardware: 
         Few connections or wireless connection using Bluetooth
         Transportable or handheld
         No maintenance
COST EFFECTIVE
  • Economical day-to-day use
  • Disposables - 6 electrodes per patient only
  • Low cost compared to invasive or other noninvasive technologies
  • Saves valuable time for operators
  • No indirect costs (catheter complications)
  • May improve patient outcome
  • Potential direct or indirect revenue generator
UNIQUE FEATURES
  • Potentially more efficient than other invasive or noninvasive hemodynamic systems thanks to similar accuracy, but better reproducibility and sensitivity
  • Offers a combination of parameters that enables accurate evaluation of any hemodynamic condition. For instance: fluid status and optimization can be efficiently assessed and guided.
  • Features displays that enable a quick and efficient evaluation of the patient's hemodynamic equilibrium: the Hemodynamic Cross. 
  HEMODYNAMIC CROSS BROCHURE
  • The analysis of signal abnormalities is potentially extremely useful for the early diagnosis of severe pathologies    when they are still reversible.